<h4>Objectives</h4>The aim of the study is to evaluate the efficacy of anti-tumor necrosis factor (TNF)-α monotherapy versus combination anti-TNF-α and immunosuppressive therapy.<h4>Methods</h4>A single-center, retrospective, observational study was conducted on inflammatory bowel disease (IBD) children. The gene discussed is TNF; the disease is inflammatory bowel disease.